PT  - JOURNAL ARTICLE
AU  - Pietro Hiram Guzzi
AU  - Giuseppe Tradigo
AU  - Pierangelo Veltri
TI  - Intensive Care Unit Resource Planning During COVID-19 Emergency at the Regional Level: the Italian case
AID  - 10.1101/2020.03.17.20037788
DP  - 2020 Jan 01
TA  - medRxiv
PG  - 2020.03.17.20037788
4099  - http://medrxiv.org/content/early/2020/03/20/2020.03.17.20037788.short
4100  - http://medrxiv.org/content/early/2020/03/20/2020.03.17.20037788.full
AB  - Severe acute respiratory syndrome COVID-19 (SARS-CoV-2) has been declared a worldwide emergency and a pandemic disease by the World Health Organisation (WHO). It started in China in December 2019, and it is currently rapidly spreading throughout Italy, which is now the most affected country after China. There is great attention for the diffusion and evolution of the COVID-19 infection which started from the north (particularly in the Lombardia region) and it is now rapidly affecting other Italian regions. We investigate on the impact of patients hospitalisation in Intensive Care Units (ICUs) at a regional and subregional granularity. We propose a model derived from well-known models in epidemic to estimate the needed number of places in intensive care units. The model will help decision-makers to plan resources in the short and medium-term in order to guarantee appropriate treatments to all patients needing it. We analyse Italian data at regional level up to March 15th aiming to: (i) support health and government decision-makers in gathering rapid and efficient decisions on increasing health structures capacities (in terms of ICU slots) and (ii) define a scalable geographic model to plan emergency and future COVID-19 patients management using reallocating them among health structures. Finally, the here proposed model can be useful in countries where COVID-19 is not yet strongly diffused.Competing Interest StatementThe authors have declared no competing interest.Funding StatementWe did not receive any external funding.Author DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll the data used in this work are publicly available.